Insiders Are Buying These 2 ‘Strong Buy’ Stocks With Over 60% Upside

Insiders at Oracle (ORCL) and Xenon Pharmaceuticals (XENE) made significant stock purchases, indicating confidence. ORCL reported strong Q1 earnings with 30% YoY revenue growth, driven by cloud services. XENE submitted an NDA for its epilepsy drug but paused trials for depression treatments. Analysts rate both stocks as Strong Buys with over 60% upside potential.

Original reporting

finance.yahoo.com

Published Oct 7, 2026, 5:57 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Oct 7, 2026, 6:14 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

Insiders Are Buying These 2 ‘Strong Buy’ Stocks With Over 60% Upside — source image — Source · finance.yahoo.com

Decision brief

The 30-second read

$ORCLBullishLow

Why it matters

Insider buying is presented as a positive indicator, but the overall market impact is limited.

Market read

Provides traders with fresh insider‑buy data for two mid‑cap stocks, useful for short‑term positioning.

What to watch

The magnitude of the purchases is modest relative to market caps; broader market sentiment may dominate price action.

Relevance 5/10Novelty 5/10Timing: recent insider purchases reported this week

Background

The article lists two companies with recent insider purchases exceeding $1 M, framing them as strong‑buy opportunities.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$ORCLBullishMedium confidence

Context

Board member Stephen Rusckowski bought 25,000 shares for $3.48 M, raising his stake to $3.62 M.

Expected impact

likely modest upward pressure as investors view the buy as a bullish signal

Evidence & confidence

Large insider buy at current price signals confidence; no other catalyst, so impact is limited.

$XENEBullishMedium confidence

Context

CEO Ian Mortimer bought 30,000 shares for $1.12 M and CFO Thomas Kelly bought 15,000 shares for $559 K on Sep 30.

Expected impact

potential modest upside as market interprets the buys as confidence in the NDA filing

Evidence & confidence

Both top executives increased stakes after mixed news; the buys could stabilize the stock.

Market effects

Sector

Highlights continued insider confidence in cloud software and biotech sectors.

Regional

U.S. equities may see slight uplift in related tech and pharma stocks.

Global

Limited to investors tracking insider activity; no broader macro impact.

Counterpoint

What could challenge this read

Insider buys may be routine portfolio rebalancing rather than a strong bullish signal.

Key entities

person
Stephen Rusckowski
Board member of Oracle who made a $3.48 M purchase.
person
Ian Mortimer
CEO of Xenon Pharmaceuticals who bought 30,000 shares.

Read at source ← All news

$CRWVHighAI 8/10

Smaller AI Spending Forecasts, Sold-Out Computing Power: Both Can Be True

Analysts revised AI data center spending forecasts to $3-4 trillion by 2030, down from $7 trillion. CoreWeave (CRWV) reported strong Q3 results with 168.3% revenue growth, oversubscribed demand, and raised guidance. Oracle (ORCL) saw 121% cloud infrastructure revenue growth and high GPU utilization. Vertiv (VRT) reported 61.2% revenue growth, with full-year guidance raised. All companies highlight strong demand and capacity constraints in the AI sector.

247wallst.comNov 12

$ORCLMed

Oracle Breaks Ground on New Global Headquarters in Nashville, Promising Jobs and Investment

Oracle (ORCL) broke ground on a new 78-acre global headquarters in Nashville, promising 7,000 jobs and a $175 million infrastructure investment. The campus will include offices, retail, a hotel, and recreational areas, with the first buildings opening by 2030. Oracle aims to collaborate with local businesses, educational institutions, and healthcare organizations, while also addressing potential challenges like increased competition and rising costs.

smallbiztrends.comNov 12

$ORCLLow

Saline Township sticks with Oracle tax break for data center amid protest

Saline Township trustees reaffirmed a 12-year, 50% tax break for Oracle's $43.1B AI data center, despite resident protests over environmental and legal concerns. The board also ratified the Industrial Development District's creation. Oracle officials declined to comment. The project is expected to create jobs and generate annual revenue for the township.

detroitnews.comNov 12

$NVDAHighAI 8/10

Nasdaq futures drop 0.8% as WSJ says Nvidia board is preparing to oust CEO Huang

Nasdaq 100 futures dropped 0.8% after the Wall Street Journal reported Nvidia's board may oust CEO Jensen Huang. Nvidia shares fell 4.5% after-hours to $166, while related companies like Super Micro Computer and Oracle declined. AMD rose 3.8%, potentially benefiting from Nvidia's disruption. Nvidia reports earnings on November 17.

investinglive.comNov 11

$ORCLHighAI 9/10

Oracle Stock Just Surged After CoreWeave Earnings. Here's Why One Analyst Says It's Built for the Data-Center Backlash

Oracle (ORCL) shares rose 9% to $128 after CoreWeave (CRWV) raised its revenue forecast and reported a $132.5B order backlog. CoreWeave's CEO cited customer prepayments as a sign of strong AI demand, easing investor concerns. Mizuho analysts believe Oracle is well-positioned due to its advanced data center construction and existing permits. Oracle's cloud infrastructure revenue doubled to $7.4B in Q2, with total revenue up 30% to $19.3B.

fool.comNov 11

$ORCLHigh

Why Oracle Stock Is Up Today

Oracle (NYSE:ORCL) stock rose 9.3% after CoreWeave (NASDAQ:CRWV) reported strong Q3 results, easing market concerns about AI cloud financing. CoreWeave's revenue surged 168% to $3.66B, beating estimates and raising guidance. Both companies face similar AI financing questions, with Oracle investing heavily in AI data centers.

finance.yahoo.comNov 11